美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA208039"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
59651-973-60 59651-973 HUMAN PRESCRIPTION DRUG DABIGATRAN ETEXILATE DABIGATRAN ETEXILATE CAPSULE ORAL 20250514 N/A ANDA ANDA208039 Aurobindo Pharma Limited DABIGATRAN ETEXILATE MESYLATE 75 mg/1 60 CAPSULE in 1 BOTTLE (59651-973-60)
59651-973-61 59651-973 HUMAN PRESCRIPTION DRUG DABIGATRAN ETEXILATE DABIGATRAN ETEXILATE CAPSULE ORAL 20250514 N/A ANDA ANDA208039 Aurobindo Pharma Limited DABIGATRAN ETEXILATE MESYLATE 75 mg/1 10 BLISTER PACK in 1 CARTON (59651-973-61) / 6 CAPSULE in 1 BLISTER PACK
59651-974-60 59651-974 HUMAN PRESCRIPTION DRUG DABIGATRAN ETEXILATE DABIGATRAN ETEXILATE CAPSULE ORAL 20250514 N/A ANDA ANDA208039 Aurobindo Pharma Limited DABIGATRAN ETEXILATE MESYLATE 110 mg/1 60 CAPSULE in 1 BOTTLE (59651-974-60)
59651-974-61 59651-974 HUMAN PRESCRIPTION DRUG DABIGATRAN ETEXILATE DABIGATRAN ETEXILATE CAPSULE ORAL 20250514 N/A ANDA ANDA208039 Aurobindo Pharma Limited DABIGATRAN ETEXILATE MESYLATE 110 mg/1 10 BLISTER PACK in 1 CARTON (59651-974-61) / 6 CAPSULE in 1 BLISTER PACK
59651-975-60 59651-975 HUMAN PRESCRIPTION DRUG DABIGATRAN ETEXILATE DABIGATRAN ETEXILATE CAPSULE ORAL 20250514 N/A ANDA ANDA208039 Aurobindo Pharma Limited DABIGATRAN ETEXILATE MESYLATE 150 mg/1 60 CAPSULE in 1 BOTTLE (59651-975-60)
59651-975-61 59651-975 HUMAN PRESCRIPTION DRUG DABIGATRAN ETEXILATE DABIGATRAN ETEXILATE CAPSULE ORAL 20250514 N/A ANDA ANDA208039 Aurobindo Pharma Limited DABIGATRAN ETEXILATE MESYLATE 150 mg/1 10 BLISTER PACK in 1 CARTON (59651-975-61) / 6 CAPSULE in 1 BLISTER PACK
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2025 Drugfuture->U.S. FDA National Drug Code DataBase